The Concept of «Peritumoral Zone» in Diffuse Low-Grade Gliomas: Oncological and Functional Implications for a Connectome-Guided Therapeutic Attitude
- PMID: 35448035
- PMCID: PMC9032126
- DOI: 10.3390/brainsci12040504
The Concept of «Peritumoral Zone» in Diffuse Low-Grade Gliomas: Oncological and Functional Implications for a Connectome-Guided Therapeutic Attitude
Abstract
Diffuse low-grade gliomas (DLGGs) are heterogeneous and poorly circumscribed neoplasms with isolated tumor cells that extend beyond the margins of the lesion depicted on MRI. Efforts to demarcate the glioma core from the surrounding healthy brain led us to define an intermediate region, the so-called peritumoral zone (PTZ). Although most studies about PTZ have been conducted on high-grade gliomas, the purpose here is to review the cellular, metabolic, and radiological characteristics of PTZ in the specific context of DLGG. A better delineation of PTZ, in which glioma cells and neural tissue strongly interact, may open new therapeutic avenues to optimize both functional and oncological results. First, a connectome-based "supratotal" surgical resection (i.e., with the removal of PTZ in addition to the tumor core) resulted in prolonged survival by limiting the risk of malignant transformation, while improving the quality of life, thanks to a better control of seizures. Second, the timing and order of (neo)adjuvant medical treatments can be modulated according to the pattern of peritumoral infiltration. Third, the development of new drugs specifically targeting the PTZ could be considered from an oncological (such as immunotherapy) and epileptological perspective. Further multimodal investigations of PTZ are needed to maximize long-term outcomes in DLGG patients.
Keywords: brain connectome; epilepsy; low-grade glioma; peritumoral zone; quality of life; surgery.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Louis D.N., Perry A., Wesseling P., Brat D.J., Cree I.A., Figarella-Branger D., Hawkins C., Ng H.K., Pfister S.M., Reifenberger G., et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro-Oncol. 2021;23:1231–1251. doi: 10.1093/neuonc/noab106. - DOI - PMC - PubMed
-
- Pedeutour-Braccini Z., Burel-Vandenbos F., Gozé C., Roger C., Bazin A., Costes-Martineau V., Duffau H., Rigau V. Microfoci of Malignant Progression in Diffuse Low-Grade Gliomas: Towards the Creation of an Intermediate Grade in Glioma Classification? Virchows Arch. 2015;466:433–444. doi: 10.1007/s00428-014-1712-5. - DOI - PubMed
-
- Roodakker K.R., Alhuseinalkhudhur A., Al-Jaff M., Georganaki M., Zetterling M., Berntsson S.G., Danfors T., Strand R., Edqvist P.H., Dimberg A., et al. Region-by-Region Analysis of PET, MRI, and Histology in En Bloc-Resected Oligodendrogliomas Reveals Intra-Tumoral Heterogeneity. Eur. J. Nucl. Med. Mol. Imaging. 2019;46:569–579. doi: 10.1007/s00259-018-4107-z. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
